Frequency and clinicoeconomic impact of delays to definitive diagnosis of obstructive hypertrophic cardiomyopathy in the United States.

Srihari S NaiduMegan B SuttonWei GaoJennifer T FineJipan Xie Nihar R Desai Anjali Tiku Owens

Published in: Journal of medical economics (2023)

Most patients with obstructive HCM had a delay of ≤ 2 years before receiving the definitive diagnosis. The diagnostic journey involved multiple potential misdiagnoses, predominantly cardiovascular, as well as a substantial clinical and economic burden on patients and the healthcare system.

Keyphrases

hypertrophic cardiomyopathy
left ventricular
end stage renal disease
ejection fraction
newly diagnosed
locally advanced
risk assessment
rectal cancer
human health
patient reported